Medical News
Noninvasive Ventilation Vs. High-Flow Nasal Cannula Oxygen f...
Ann Intensive Care.
Patients with obesity and acute hypoxemic respiratory failure had an increased risk of severe hypoxemia during...
23 Jul 2021
Early Warning of Bloodstream Infection in Elderly Patients w...
Ann Intensive Care.
The early warning model of bloodstream infection based on circulating T-MPs, NMPs, and monocyte counts within 6 h...
20 Jul 2021
Transpulmonary Pressure-Guided Lung-Protective Ventilation I...
Respir Care.
PL-guided LPV resulted in higher PEEP, lower , improved pulmonary mechanics, and greater oxygenation when compared...
14 Jul 2021
Analysis of Noninvasive Ventilation in Subjects with Sepsis...
Respir Care.
NIV failure in sepsis-related acute respiratory failure was independently predicted by patient acuity, first...
14 Jul 2021
eCMEs
Key Trials
Pharmacokinetics and Pharmacodynamics of Imipenem by Two-Step and Extended Infusions in Sepsis Patients
The pharmacokinetic/pharmacodynamic (PK/PD) parameters achieved in two-step and extended regimens of imipenem were comparable in the treatment of...
Benefits of Inhaled Budesonide in Early COVID-19 Infection: STOIC Study
This infographic summarises the key points of the STOIC study and outlines the benefits of administering inhaled budesonide in early COVID-19...
Utility of C-Reactive Protein Based Protocol in the Duration of Antibiotic Therapy in Critically Ill Patients
A protocol based on daily monitoring of C-reactive protein levels may allow early interruption of antibiotic therapy in a higher proportion of...
Novel Antibiotic Adjuvant Entity Might Be an Effective Empirical Therapy for Treating Nosocomial Infections
It can be concluded that the use of CSE 1034 of ceftriaxone, sulbactam, and ethylenediaminetetraacetic acid is an effective option for the treatment...
Slide Library
Cefuroxime (Novacef)
Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....
Management of Mucormycosis in ENT Practice
Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...
Antifungal Therapy in Immunocompromised Patients
Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...
Disseminated Tuberculosis with ARDS
Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...
Our Publications
Cytorx (Flucytosine) Monograph
This monograph describes the role of Flucytosine tablets in the management of invasive cryptococcal infections and some Candida spp. infections.
Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections
Parenteral macrolide therapy is needed for patients with moderate to severe CAP/AECB. This booklet gives an overview of the efficacy and safety of...
MRSA: The Clinician’s Challenge
The article summarizes the Indian epidemiological data for MRSA infections, along with treatment of MRSA infections and infection control measures.
Phosome IV (Liposomal Amphotericin B) Monograph
Amphotericin B deoxycholate has a broad antifungal activity, and today it is the best antifungal available against most systemic fungal infections,...
Poll
Do you perceive any clinical benefits of neurotrophic agent in the management of acute brain injury?
Yes
Sometimes
No
Total votes: 10